retatrutide microdosing protocol Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Dosing Guide: 1-12 mg

Under this plan, Medicare recipients are expected to be covered for GLP-1s, with a $50 monthly cap on patient out-of-pocket spending

So, if you have a diagnosis of type 2 diabetes, your insurance plan may cover the medication

April 10, 2026

Dosing schedules are based on the Phase 3 TRIUMPH clinical trial protocols

Thus, without going into too many methodological details, there are questions about whether or not the approach used in this study fully explored (or rules out) the role of GLP-1 in the hypoglycaemic response

However, diastolic blood pressure may also improve in some patients, especially when weight loss and metabolic health improve